Pancreatic Cancer Research

ResearcherHarold C. Simmons Comprehensive Cancer CenterActive in the last 2 years

Salwan S. Al Mutar

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-3557-7525; OpenAlex author ID A5077797987. Sources: ClinicalTrials.gov.

Their work

Papers
2
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2017: 1 trial · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers

Papers 2

  1. Post-operative patterns of failure and outcomes reveal opportunities to optimize treatment of recurrent pancreatic cancer Co-author DOI 10.1101/2025.11.08.25339815↗
  2. Presurgical Ablative Radiation Is Associated with Local Control and Immune Response in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-24-3582↗

Trials 1

  1. Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer Principal investigator NCT02902484↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nina Niu Sanford · 2 shared papers, 2025 · strength 0.41
  2. Patricio Marcelo Polanco · 2 shared papers, 2025 · strength 0.41
  3. Ahmed M. Elamir · 2 shared papers, 2025 · strength 0.41
  4. Syed Mohammad Ali Kazmi · 2 shared papers, 2025 · strength 0.41
  5. Todd Anthony Aguilera · 2 shared papers, 2025 · strength 0.41
  6. Peter Q. Leung · 2 shared papers, 2025 · strength 0.41
  7. Matthew R. Porembka · 2 shared papers, 2025 · strength 0.41
  8. Herbert J. Zeh · 2 shared papers, 2025 · strength 0.41
  9. John Michael P. Tomagan · 1 shared paper, 2025 · strength 0.23
  10. Shahed Nicolas Badiyan · 1 shared paper, 2025 · strength 0.23
  11. John C. Mansour · 1 shared paper, 2025 · strength 0.18
  12. Zhikai Chi · 1 shared paper, 2025 · strength 0.18
  13. Muhammad Shaalan Beg · 1 shared paper, 2025 · strength 0.18
  14. Adam Charles Yopp · 1 shared paper, 2025 · strength 0.18
  15. Megan Wachsmann · 1 shared paper, 2025 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.